Antitrypsin Deficiency Stocks List

Antitrypsin Deficiency Stocks Recent News

Date Stock Title
Jul 1 ALNY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 ALNY Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
Jun 29 ALNY Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
Jun 27 BAX Did Baxter International Inc. (BAX) Beat the Market in Q1?
Jun 27 ALNY Peering Into Alnylam Pharmaceuticals's Recent Short Interest
Jun 27 ALNY Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Jun 27 NTLA Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
Jun 27 BEAM Beam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study
Jun 27 BAX Wall Street Breakfast Podcast: SpaceX Said To Hit $210B Valuation, Wins $843M NASA Deal
Jun 27 BAX Baxter issues Class 1 recall of Life2000 ventilators over battery charging issue
Jun 27 NTLA Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
Jun 26 BAX Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Jun 26 BAX Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Jun 26 NTLA Intellia Therapeutics appoints CFO
Jun 26 NTLA Intellia Therapeutics Announces CFO Transition
Jun 26 BEAM Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)
Jun 26 NTLA First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
Jun 25 NTLA Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
Jun 25 ALNY Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Jun 25 NTLA 3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Antitrypsin Deficiency

Antitrypsin Deficiency is a genetic disorder that affects the lungs and liver. It is caused by a deficiency of the protein alpha-1 antitrypsin (AAT), which is produced in the liver and helps protect the lungs from damage. People with Antitrypsin Deficiency are at an increased risk of developing lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD). They may also be at risk of developing liver disease. Treatment for Antitrypsin Deficiency includes lifestyle changes, medications, and in some cases, a liver transplant.

Browse All Tags